Clin Exp Otorhinolaryngol.  2014 Sep;7(3):238-239. 10.3342/ceo.2014.7.3.238.

In Reply: IgG4 Related Disease and Sensorineural Hearing Loss

• Cho HK
• Lee YJ
• Chung JH
• Koo JW

• KMID: 1973479
• DOI: http://doi.org/10.3342/ceo.2014.7.3.238

Abstract

No abstract available.

MeSH Terms

Hearing Loss, Sensorineural*
Immunoglobulin G*
Immunoglobulin G

Figure

• 

  Fig. 1 Pure tone audiogram demonstrating fluctuation of bilateral mixed hearing loss. Air-bone gap was improved during the period of immunosuppressive therapy (black bars). R, right; BC, bone conduction threshold; AC, air conduction threshold; L, left.

Reference

1. Cho HK, Lee YJ, Chung JH, Koo JW. Otologic manifestation in IgG4-related systemic disease. Clin Exp Otorhinolaryngol. 2011; 3. 4(1):52–54. PMID: 21461065.

2. Ohara H, Nakazawa T, Sano H, Ando T, Okamoto T, Takada H, et al. Systemic extrapancreatic lesions associated with autoimmune pancreatitis. Pancreas. 2005; 10. 31(3):232–237. PMID: 16163054.

3. Roverano S, Cassano G, Paira S, Chiavarini J, Graf C, Rico L, et al. Asymptomatic sensorineural hearing loss in patients with systemic lupus erythematosus. J Clin Rheumatol. 2006; 10. 12(5):217–220. PMID: 17023806.

4. Saeki T, Saito A, Hiura T, Yamazaki H, Emura I, Ueno M, et al. Lymphoplasmacytic infiltration of multiple organs with immunoreactivity for IgG4: IgG4-related systemic disease. Intern Med. 2006; 45(3):163–167. PMID: 16508232.

5. Kamisawa T, Okamoto A. IgG4-related sclerosing disease. World J Gastroenterol. 2008; 7. 14(25):3948–3955. PMID: 18609677.